Viewing Study NCT07332156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-05-24 @ 12:53 AM
Study NCT ID: NCT07332156
Status: COMPLETED
Last Update Posted: 2026-01-14
First Post: 2025-12-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Sponsor: Samsung Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
None COPD (Chronic Obstructive Pulmonary Disease) View
None Lung Cancer (Diagnosis) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SGLT2 inhibitor View
None Sulfonylurea View
None T2DM with COPD View
None Lung cancer View